Drug pricing, reimbursement issues to remain key barriers to pharmaceutical sector growth: GlobalData
GlobalData has identified drug pricing and reimbursement-related concerns as the key impediment to the pharmaceutical industry’s growth in 2022.
These barriers could even force pharmaceutical...
Diabetes drug prescriptions rises eight million since 2015, NHS report says
Nearly 60 million drugs were used to treat people with diabetes in England last year, increasing eight million since 2015-16, a report by the...